Persbericht

16/01/2019 Asit biotech -Ongoing restructuring of ASIT biotech organization (16.1.2019)
15/01/2019 Total-Main indicators (15.1.2019)
15/01/2019 EURONAV VERKOOPT SUEZMAX FELICITY VOOR OFFSHOREPROJECT (15.1.2019)
14/01/2019 Deceuninck So Easy joint venture (14.01.2019)
14/01/2019 MDxHealth Provides Business Update (14.1.2019)
11/01/2019 Anheuser-Busch InBev Kondigt Prijsbepaling aan van USD 15,5 miljard Obligaties (11.1.2019)
10/01/2019 Total-Brendan Warn is appointed Senior Vice-President Investor Relations (10.1.2019)
10/01/2019 Elia publiceert verkiezingsmemorandum (10.1.2019)
10/01/2019 Proximus lanceert zijn #shifttodigital strategie (10.1.2019)
09/01/2019 Ageas- BlackRock boven 5% (9.1.2019)
10/01/2019 Van de Velde-Jaaromzet 2018 in lijn met de verwachtingen (10.1.2019)
09/01/2019 Umicore- Blackrock boven drempel 5% ( 9.1.2019)
09/01/2019 ENGIE -acquisition of SUEZ’s nuclear maintenance activity (9.1.2019)
09/01/2019 QRF-Resultaten Buitengewone Algemene Vergadering (9.1.2018)
09/01/2019 Galapagos-Sands Capital meldt 5,7% deelneming (9.1.2019)
09/01/2019 EVENITY® (romosozumab) Receives Approval In Japan for the Treatment of Osteoporosis In Patients at High Risk of Fracture (9.1.2019)
08/01/2019 Euronext announces volumes December (8.1.2019)
08/01/2019 Elia rondt succesvolle uitgifte af voor obligatielening van € 500 miljoen (8.1.2019)
07/01/2019 Celyad Outlines Key 2019 Priorities Including theAcceleration of the CYAD-01 Program in AML and MDS (7.1.2018)
07/01/2019 Galapagos lanceert NOVESA Fase 2a-studie in patiënten met systemische sclerose (7.1.2019)